Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine versus placebo in symptomatic diverticular disease
ISRCTN10958581Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of Salcrozine in diverticular disease, sponsored by University of Nottingham. Primary endpoint: Change in galanin expression in mucosal nerves. Started Aug 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticular disease
Beyond the preview
Go deeper on ISRCTN10958581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10958581.